Clinical Trial Detail

NCT ID NCT03275597
Title Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition
Recruitment Recruiting
Gender
Phase Phase I
Variant Requirements yes
Sponsors University of Wisconsin, Madison
Indications

non-small cell lung carcinoma

Therapies

Durvalumab + Tremelimumab

Age Groups: senior adult

Additional content available in CKB BOOST